Novartis CEO, Joseph Jimenez, is interviewed by the WSJ's Marta Falconi. Jimenez sees the need to focus on patient outcomes and giving payers incentive by reducing total hospitalization cost through better drugs. One area he sees the pharmaceutical industry needing to change is to invest more in R&D, and less in sales and marketing.